Kirpekar Sahil 4
4 · ATAI Life Sciences N.V. · Filed Dec 2, 2022
Insider Transaction Report
Form 4
Kirpekar Sahil
Chief Business Officer
Transactions
- Award
Stock Option
2022-12-01+750,000→ 750,000 totalExercise: $3.34Exp: 2032-12-01→ Common Shares (750,000 underlying)
Footnotes (1)
- [F1]The stock option shall vest as to 25% of the underlying shares on November 29, 2023, and in 36 substantially equal monthly installments thereafter.